Akso Health Group (AHG) Fair Value 2026

AHG · Medical Distribution ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

2.2 /10

32 fundamental signals · 0 models active

Value Trap Risk

DANGER (80/100)

Quick Summary — As of 2026-08-28, Akso Health Group (AHG) trades at $0.86. QOC: 2.2/10. Value Trap Risk: 80/100 (DANGER). 0/13 models active.

Key Facts

Ticker
AHG
Price
$0.86
Quality Score
2.2/10
Value Trap Risk
80/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 80 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give AHG?

0 Intrinsic Value Models vs. Current Price ($0.86)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Akso Health Group (AHG) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Akso Health Group currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About AHG?

0 of 13 models are currently active for AHG. See which stocks rank higher →

How Does AHG Rank in Medical Distribution?

Among 13 Medical Distribution stocks, AHG ranks #13 by Quality of Company score. CirclFi's QOC score of 2.2/10 evaluates 32 fundamental signals. A score of 2.2 signals below-average fundamentals.

Akso Health Group operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is AHG a Value Trap?

CirclFi's Value Trap algorithm assigns AHG a score of 80/100 (DANGER). This is a high-risk signal. Deteriorating fundamentals suggest the discount may be justified. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Akso Health Group. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Akso Health Group earns a quality score of 2.2/10. This concerning rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. However, our Value Trap algorithm flags elevated risk — suggesting that apparent cheapness may mask deteriorating fundamentals.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every AHG valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Akso Health Group Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Distribution Stocks Should You Also Analyze?

8 related Medical Distribution stocks with 13-model coverage

HKPDCellyan Biotechnology Co., LtdQOC 2.5MCKMcKesson CorporationQOC 8.7MEDSDataMEDS AI, Inc.QOC 4.3CORCencora, Inc.QOC 8.3COSMCosmos Health Inc.QOC 4.5CAHCardinal Health, Inc.QOC 7.9ACHAccendra Health, Inc.QOC 5.8SNYRSynergy CHC Corp.QOC 4.6

Read investment analysis: HKPD · MCK · MEDS · COR · COSM · CAH · ACH · SNYR

Which Other Stocks Have a Similar Quality Score to AHG?

7 companies across all industries closest to AHG’s Quality of Company score of 2.2/10.

NCELNewcelX Ltd.QOC 2.2HLPHongli Group Inc.QOC 2.2DXYZDestiny Tech100 Inc.QOC 2.2DOGZDogness (International) CorporationQOC 2.2FSCOFS Credit Opportunities Corp.QOC 2.2BNRGBrenmiller Energy LtdQOC 2.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: NCEL · HLP · DXYZ · DOGZ · FSCO · BNRG · NVDA

What Else Do Investors Ask About Akso Health Group’s Valuation?

What is Akso Health Group's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Akso Health Group (AHG). The Quality of Company score is 2.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is AHG overvalued or undervalued right now?

At $0.86, 0 of 0 active models suggest AHG may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Akso Health Group's business model in Medical Distribution.

What does a Quality of Company score of 2.2 mean for AHG?

Akso Health Group's QOC of 2.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on AHG?

CirclFi analyzes AHG with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is AHG a value trap in 2026?

Akso Health Group's Value Trap score is 80/100 (DANGER). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Akso Health Group (AHG) a Quality of Company score of 2.2/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/AHG/ · Methodology
Primary sources for this AHG valuation
  • Financial statements: Akso Health Group 10-K and 10-Q filings on SEC EDGAR (CIK 0001702318) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for AHG as of ; valuations recomputed .